Abstract
Testing for hepatitis C virus by ELISA requires confirmation by recombinant immunoblot assay (RIBA). The first-generation RIBA uses the same antigen as used in the ELISA and one further antigen. A second-generation RIBA in which two further antigens are present, detects positivity that is not found by either the ELISA or the original RIBA. Consequently, although it is adequate to test Elisa positive sera with the first-generation RIBA, the second-generation assay is recommended for confirming negativity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Skidmore S. Recombinant immunoblot assay for hepatitis C antibody (1990) Lancet 335: 1346
Van Der Poel CL, Cuypers HTM, Reesink HW et al (1991) Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet 337: 317–319
Wong DC, Diwan AR, Rosen L et al (1990) Non-specificity of anti-HCV test for seroepidemiological analysis. Lancet i: 750–751
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag
About this paper
Cite this paper
Taliani, G. et al. (1992). Recombinant immunoblot assay for hepatitis C virus antibody in chronic hepatitis. In: De Bac, C., Taliani, G., Gerlich, W.H. (eds) Chronically Evolving Viral Hepatitis. Archives of Virology, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-5633-9_50
Download citation
DOI: https://doi.org/10.1007/978-3-7091-5633-9_50
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82350-7
Online ISBN: 978-3-7091-5633-9
eBook Packages: Springer Book Archive